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Intersubunit cross-talk in pyridoxal 5'-phosphate synthase,
coordinated by the C terminus of the synthase subunit
Abstract
Vitamin B(6) is essential in all organisms, due to its requirement as a cofactor in the form of pyridoxal
5'-phosphate (PLP) for key metabolic enzymes. It can be synthesized de novo by either of two pathways
known as deoxyxylulose 5-phosphate (DXP)-dependent and DXP-independent. The DXP-independent
pathway is the predominant pathway and is found in most microorganisms and plants. A glutamine
amidotransferase consisting of the synthase Pdx1 and its glutaminase partner, Pdx2, form a complex that
directly synthesizes PLP from ribose 5-phosphate, glyceraldehyde 3-phosphate, and glutamine. The
protein complex displays an ornate architecture consisting of 24 subunits, two hexameric rings of 12
Pdx1 subunits to which 12 Pdx2 subunits attach, with the glutaminase and synthase active sites remote
from each other. The multiple catalytic ability of Pdx1, the remote glutaminase and synthase active sites,
and the elaborate structure suggest regulation of activity on several levels. A missing piece in
deciphering this intricate puzzle has been information on the Pdx1 C-terminal region that has thus far
eluded structural characterization. Here we use fluorescence spectrophotometry and protein chemistry to
demonstrate that the Pdx1 C terminus is indispensable for PLP synthase activity and mediates
intersubunit cross-talk within the enzyme complex. We provide evidence that the C terminus can act as
a flexible lid, bridging as well as shielding the active site of an adjacent protomer in Pdx1. We show that
ribose 5-phosphate binding triggers strong cooperativity in Pdx1, and the affinity for this substrate is
substantially enhanced upon interaction with the Michaelis complex of Pdx2 and glutamine.
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Vitamin B6 is essential in all organisms, due
to its requirement as a cofactor in the form of
pyridoxal 5´-phosphate for key metabolic
enzymes. It can be synthesized de novo by
either of two pathways known as
deoxyxylulose 5-phosphate (DXP)-dependent
and DXP-independent. The DXP-independent
pathway is the predominant pathway and is
found in most microorganisms and plants. A
glutamine amidotransferase consisting of the
synthase Pdx1, and its glutaminase partner,
Pdx2, form a complex that directly
synthesizes PLP from ribose 5-phosphate,
glyceraldehyde 3-phosphate and glutamine.
The protein complex displays an ornate
architecture consisting of 24 subunits, two
hexameric rings of 12 Pdx1 subunits to which
12 Pdx2 subunits attach, with the glutaminase
and synthase active sites remote from each
other. The multiple catalytic ability of Pdx1,
the remote glutaminase and synthase active
sites and the elaborate structure, suggest
regulation of activity on several levels. A
missing piece in deciphering this intricate
puzzle has been information on the Pdx1 C-
terminal region that has thus far eluded
structural characterization. Here we use
fluorescence spectrophotometry and protein
chemistry to demonstrate that the Pdx1 C-
terminus is indispensable for PLP synthase
activity and mediates intersubunit crosstalk
within the enzyme complex. We provide
evidence that the C-terminus can act as a
flexible lid, bridging as well as shielding the
active site of an adjacent protomer in Pdx1.
We show that ribose 5-phosphate binding
triggers strong cooperativity in Pdx1, and the
affinity for this substrate is substantially
enhanced upon interaction with the Michaelis
complex of Pdx2 and glutamine.
It was long assumed that de novo biosynthesis of
vitamin B6 could only be achieved by the DXP-
dependent pathway, characterized extensively
for Escherichia coli (1,2), which generates the
active cofactor form via pyridoxine 5’-phosphate
(PNP) from erythrose 4-phosphate and
glyceraldehyde 3-phosphate through a sequence
of reactions requiring the participation of seven
enzymes. Recently, an alternative route has
come to light that directly results in the
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2biosynthesis of the cofactor form of the vitamin,
pyridoxal 5´-phosphate (PLP). Moreover, most
organisms that can make this essential
compound, i.e. microorganisms and plants, in
fact utilize this alternative pathway.
Remarkably, the newly discovered pathway
involves the interplay of just two proteins, a
synthase (named Pdx1) and a glutaminase
(named Pdx2), jointly displaying glutamine
amidotransferase activity (3,4). Pdx1 and Pdx2
assemble into a 24-subunit complex (12 Pdx1
and 12 Pdx2 subunits) to form the functional
vitamin B6 biosynthesis machinery (5,6). The
intrinsic reactions of the synthase and
glutaminase occur at sites distant from each
other, separated by approximately 26 Å. The
Pdx2 active site, where glutamine is hydrolyzed
to glutamate and ammonia, is located at the
interface between Pdx2 and the N-terminus of
Pdx1, whereas the active site of Pdx1 is located
at the C-terminal end of its (β/α)8-barrel (5,6).
During the course of PLP synthesis, ammonia
from the hydrolysis of glutamine in the Pdx2
active site is channelled to the Pdx1 active site
via a putative tunnel, assumed to be inaccessible
to solvent, that runs through the core of the Pdx1
(β/α)8-barrel (5). At the Pdx1 active site, a
pentose phosphate and triose phosphate sugar,
i.e. ribose 5-phosphate and glyceraldehyde 3-
phosphate, are combined along with ammonia to
form PLP. As the active sites of Pdx1 and Pdx2
are remote from each other, tight regulation of
enzyme activities coordinated by interdomain
signalling is expected. So far, studies have
primarily focused on the interaction of Pdx1
with Pdx2 and the direct effect of Pdx1 on the
glutaminase activity of Pdx2. Signalling from
Pdx2 to the Pdx1 active site as well as
transmission of an interdomain signal between
the individual Pdx1 monomers to explain the
ornate dodecameric architecture have not yet
been explored.
X-ray crystallography and biochemical
studies have facilitated characterization of the
heteromeric PLP synthase, as well as of the
individual subunits at the molecular level. The
structure of the individual glutaminase subunit
Pdx2 was the first to be reported and provided
insight into the active site architecture (7,8).
This was followed by the description of the Pdx1
oligomer (9) and shortly thereafter the
Pdx1/Pdx2 complex was solved independently
by two groups (5,6). A comparison of the
structures of the individual subunits with that of
the Pdx1/Pdx2 complex revealed areas that
become ordered upon assembly of PLP synthase.
In Pdx1, these include the N-terminal tail
(residues 2-6), a N-terminal α-helix (residues 7-
17), and residues 47-56 that comprise α-helix 2′
(Note: annotation and numbering is that of the
Bacillus subtilis protein (5)). The N-terminal
ordered regions are mainly involved in the
interaction with Pdx2, while the function of
helix 2′ is not yet clear. However, in no case
could structural information be provided on
residues 270-294 of the Pdx1 C-terminus,
presumably due to inherent flexibility.
Interestingly, in the presence of the pentose
phosphate substrate, part of the C-terminal
region is observed in the Thermotoga maritima
protein (residues 270-280) (6). However, the
remainder of the C-terminus of Pdx1 (15
residues) has eluded structural analysis and
remains to be characterized.
Here we report on conformational changes
in the Pdx1 protein upon assembly of the
heteromeric PLP synthase complex. These occur
at two levels, comprising interdomain co-
operation between the individual Pdx1
monomers and signalling from the Pdx2 subunit
to relay tighter binding of the pentose phosphate
substrate. Employing fluorescence and UV-
Visible spectrometry combined with protein
mutagenesis, we demonstrate that the C-
terminus of Pdx1 is essential in mediating these
functionalities in PLP synthase and we provide
insight into the dynamics of this highly flexible
region, which has a major role to play in the
mechanism of this polymorphic enzyme.
Furthermore, through the use of the recently
developed technique of specific incorporation of
a photoactivatable unnatural amino acid, we
demonstrate that the vital role of the Pdx1 C-
terminus is accomplished by acting as a lever to
a neighboring protomer where it fulfills its
catalytic role.
EXPERIMENTAL PROCEDURES
Materials - p- benzoyl-phenylalanine (pBpa)
was purchased from Bachem AG (Bubendorf,
Switzerland). Recombinant trypsin (proteomics
grade) was from Roche Diagnostics (Rotkreuz,
Switzerland).
Equilibrium binding monitored by intrinsic
protein fluorescence - All steady-state
3fluorescence measurements were conducted on a
QuantaMaster 4 spectrofluorometer (Photon
Technology International, Seefeld, Germany).
All spectra were acquired in 20 mM Tris-Cl pH
7.5 containing 10 mM NaCl and at 23°C. The
fluorescence emission spectra of the individual
proteins were acquired from 305 to 550 nm after
excitation at 295 nm using either 2 µM Pdx1 or
Pdx1 ΔW294, and either 4 µM or 20 µM of
Pdx2 H170N in the presence or absence of 1
mM glutamine, as indicated. Data were recorded
in increments of 1 nm with an integration time
of one second. Each spectrum was corrected for
dilution effects. Bandwidths of the excitation
and emission monochromator were set to 4 and 8
nm, respectively. For the fluorimetric titration,
Pdx1 (either 0.3 µM or 2 µM) was incubated
with varying concentrations of Pdx2 H170N (0-6
µM) in the presence of 1 mM glutamine, and the
fluorescence emission at the λmax of 350 nm was
measured for 10 seconds, averaged and
corrected for dilution effects and for any
fluorescence signal caused by Pdx2 H170N
(photobleaching was negligible with these
experimental settings). Samples were pre-
incubated for 5 min at 23°C prior to the
measurement. Equilibrium binding data were
analysed employing nonlinear fitting routines to
equation 1:
€ 
F Pdx2H170N[ ]( ) = F0 −
ΔF
2 ⋅ Pdx1[ ]
⋅ Pdx1[ ] + Pdx2H170N[ ] + Kd( ) − Pdx1[ ] + Pdx2H170N[ ] + Kd( )
2
− 4 Pdx1[ ] ⋅ Pdx2H170N[ ]( )   
 
 
 
F([Pdx2H170N]) is the fluorescence signal at a
given Pdx2 H170N concentration, F is the
maximal fluorescence signal, ΔF is the maximal
change in fluorescence intensity, [Pdx1] is the
Pdx1 concentration, [Pdx2 H170N] is the Pdx2
H170N concentration and Kd is the dissociation
constant. The steady state kinetics for ribose 5-
phosphate binding displayed sigmoidal
behaviour and were thus determined by
nonlinear curve fitting to the Hill equation:
€ 
F( R5P[ ]) = F0 +
ΔF ⋅ R5P[ ]h
K0.5h + R5P[ ]h
F([R5P]) is the fluorescence signal at a given
ribose 5-phosphate concentration, F0 is the
maximal fluorescence signal, ΔF is the maximal
change in fluorescence intensity, [R5P] is the
ribose 5-phosphate concentration, K0.5 is the
ribose 5-phosphate concentration at half-
maximal fluorescence signal and h is the Hill
coefficient.
Pre steady-state kinetics followed by intrinsic
protein fluorescence - Rapid kinetic
measurements were performed using an Applied
Photophysics SX.18MV stopped-flow
spectrometer. The excitation wavelength was set
at 295 nm and the slit width was 15 nm. Light
emitted from the sample was monitored after
passing through a 320 nm cut-off filter. The
concentration of Pdx1 was held constant at 0.3
µM, while that of Pdx2 H170N was varied in the
range of 1.2-4.2 µM. Experiments were
performed in the presence of 1 mM glutamine in
20 mM Tris-Cl and 10 mM NaCl, pH 7.5, at
23°C. In each experiment, 8000 data points were
recorded during 200 sec, and data from five to
ten traces at identical conditions were averaged.
Photobleaching of Pdx1 over the time-course of
the reaction was subtracted from the
fluorescence signal and the end signal was
normalized according to the fluorescence
titration of Pdx2 H170N binding to Pdx1. The
normalized data was fitted to a double
exponential according to equation 3:
€ 
F(t) = F0 +α1 ⋅ exp(−t /τ1) +α2 ⋅ exp(−t /τ 2)
F(t) is the fluorescence at time t, α1 and τ1 are
the amplitude and the observed relaxation time
of the fast relaxation (α2 and τ 2 for the slow
relaxation, respectively) and Ff is the
fluorescence intensity after infinite time due to
incomplete Pdx1-Pdx2 assembly.
Crosslinking studies - Site-directed incorpor-
ation of pBpa into Pdx1 was accomplished using
the technique established by Schultz and
colleagues (10,11). This method employs an
engineered plasmid coding for an orthologous
aminoacyl tRNA synthetase pair allowing the
incorporation of unnatural amino acids at the
position of the amber stop codon. The amber
stop codon (TAG) was introduced at either R8,
Y261, R288 or W294 in Pdx1 using the
QuikChange site-directed mutagenesis kit
(Stratagene) according to the manufacturer’s
protocol. As forward and reverse primers, the
oligonucleotides (mutation underlined) 5´-
CAAACAGGTACTGAATAGGTAAAACGCG
GAATG-3´ and 5´-CATTCCGCGTTTTA-
CCTATTCAGTACCTG-TTTG-3´ were used
for R8, 5´-CACTTTACTGATTAGAAATT-
AATCGCTG-3´ and 5´-CAGCGATTAATTT-
CTAATCAGTAAAGTG-3´ for Y261, 5´-
CTTCCAGAACAGTAGATGCAAGAACGC-
3´ and 5´-GCGTTCTTGCATCTACTGTTCTG-
GAAG-3´  fo r  R288 ,  wh i l e  5 ´ -
CAAGAACGCGGCTAGCTCGAGCACCACC
AC-3´ and 5´-GTGGTGGTGCTCGAGCTAGC-
CGCGTTCTG-3´ were used for W294,
4respectively. As a template, pETBsPdx1-His6 (5)
was employed. The mutation was confirmed by
nucleotide sequencing (Microsynth AG,
Balgach, Switzerland). Two plasmids, one
(pSup-BpaRS-6TRN: p-benzoyl-phenylalanine)
endowing the host cell with the ability to
incorporate pBpa through an amber codon, and
another directing the expression of the amber
mutant form of Pdx1, were introduced into E.
coli BL21 cells using sequential heat-shock
transformation. The transformed cells were
grown at 37°C in LB medium to an O.D. of 0.6
at 600 nm. Prior to the induction of protein
expression by the addition of 0.2 mM IPTG, the
medium was supplemented with 1 mM pBpa.
Cells were incubated for another 6 h at 37°C and
then harvested by centrifugation and
subsequently stored at -80°C. The respective
hexahistidine-tagged proteins, Pdx1 R8:pBpa,
Pdx1 Y261:pBpa, Pdx1 R288:pBpa and Pdx1
W 2 9 4 : p Bpa, were purified by Ni-NTA
chromatography according to the protocol
supplied by the manufacturer (Qiagen,
Switzerland). Incorporation of the unnatural
amino acid was verified by ESI-mass
spectrometry (Protein Service at the Functional
Genomics Center Zurich, Switzerland).
Crosslinking reactions were performed in a 96-
well microtiter plate with a total reaction volume
of 100 µL in 50 mM Tris buffer, pH 7.5, on ice.
Samples were irradiated at 365 nm using the UV
Stratalinker 1800 (Stratagene, EIKO lamps
F8T5/BL) for 1 to 120 min (depending on the
experiment). Samples were analyzed by SDS-
PAGE on 12.5% polyacrylamide gels. Where
shown, immunodecoration with antibodies
against Pdx1 and Pdx2 was carried out as
described in (3).
Nano-LC separation and MALDI analysis of
tryptic peptides - One hundred µM of the Pdx1
protein sample (WT or W294:pBpa in a total
volume of 100 µL that had been subjected to 60
minutes of irradiation at 365 nm using the UV
Stratalinker 1800) was digested with 2 µg of
trypsin for 3 hours at 37 °C in 100 mM
NH4HCO3. After digestion, TFA was added to a
final concentration of 0.1 % (v/v). Peptide
separation was performed on an Ultimate
chromatography system (Dionex - LC Packings,
Sunnyvale, CA) equipped with a Probot MALDI
spotting device. Five µL of the samples were
injected by using a Famos autosampler (Dionex
- LC Packings) and loaded directly onto a 75 µm
x 150 mm reversed-phase column (PepMap 100,
3 µm; Dionex - LC Packings). Peptides were
eluted at a flow rate of 300 nL/min by using a
water/acetonitrile gradient. For MALDI analysis,
the column effluent was directly mixed with
MALDI matrix (3 mg/mL α - c y a n o - 4 -
hydroxycinnamic acid in 70 % acetonitrile/0.1 %
TFA) at a flow rate of 1.1 µL/min via a µ-Tee
fitting. Fractions were automatically deposited
every 10 s onto a MALDI target plate (Applied
Biosystems, Toronto, Canada) using a Probot
micro fraction collector. A total of 416 spots
were collected from each HPLC run. MALDI
plates were analyzed on a 4800 MALDI
TOF/TOF system (Applied Biosystems)
equipped with a Nd:YAG laser operating at 200
Hz. All mass spectra were recorded in positive
reflector mode and generated by accumulating
data from 500 laser pulses in the mass range
from m/z 750-6000. In the MSMS mode,
collision-induced dissociation spectra of selected
precursor ions were recorded at a collision
energy of 1 kV and a collision gas pressure of
approximately 2 x 10-6 Torr. Typically, spectra
from 10000 laser pulses were accumulated.
Enzyme assays - Distinct enzyme activities of
PLP synthase can be separately measured, i.e.
(1) the rate of glutamine hydrolysis by Pdx2, (2)
the formation of the end product PLP, and (3)
the formation of the chromophoric reaction
intermediate (12). All of these enzyme activities
are detectable by UV/visible spectrophotometry.
Glutaminase activity of Pdx2 was monitored by
a coupled enzyme assay as described in (3). PLP
formation was monitored by the change in
absorbance at 414 nm in the presence of ribose
5-phosphate, glyceraldehyde 3-phosphate, Pdx2
and glutamine, as described in (3,12). Formation
of the chromophoric reaction intermediate was
determined by the increase in absorbance at 315
nm in the presence of Pdx1, Pdx2, ribose 5-
phosphate and glutamine (12).
Protein expression and purification - The
constructs pETBsPdx1 and pETBsPdx2-His6
described in (3), in addition to pETBsPdx1-His6
and Pdx2-His6 H170N described in (5), were
used in this study. The mutant Pdx1 ΔW294 was
generated using the QuikChange site-directed
mutagenesis kit (Stratagene, Basel, Switzerland)
employing the oligonucleotides,  5 '-
GCAAGAACGCGGCCTCGAGCACCACC-3'
and 5'-GGTGGTGCTCGAGGCCGCGTTCTT-
GC-3' as forward and reverse primer,
5respectively, and pETBsPdx1-His6 as the
template. The Pdx1 Δ273-294 mutant was
generated using the forward and reverse
oligonucleotides, 5'-CTAGCTAGCATGGCTC-
AAACAGGTACTGAAG-3' and 5'-CCGCTC-
GAGAAGCTCTTTTGACAACTCAGCG-3',
respectively, to amplify the DNA, with
pETBsPdx1-His6 as the template. The fragment
was cloned into the NheI/XhoI restriction sites
of pET21a (EMD Biosciences, NJ, U.S.A.) such
that when expressed, a hexa-histidine tag would
be incorporated at the C-terminus. Protein
expression and purification, for both the native
and hexahistidine tagged proteins, were carried
out as described in (3) and monitored by SDS-
PAGE on either 12.5 or 15% polyacrylamide
gels and staining with Coomassie Blue. Protein
concentration was determined by the method of
Bradford (13) using bovine serum albumin as a
standard.
Partial proteolytic digestion - Thirty two µg
of Pdx1 was incubated with either 0.0005,
0.0028 or 0.005 µ g of trypsin and when
indicated, Pdx2 H170N (30 µg), in 20 mM Tris-
Cl, pH 7.5, in a total volume of 100 µl for 10
min at 37°C. When present, ribose 5-phosphate,
glyceraldehyde 3-phosphate and glutamine were
each at a final concentration of 1 mM. The
reaction was stopped by addition of formic acid
to a final concentration of 1% (v/v). One fifth of
the reaction volume was utilized to monitor the
progress of proteolytic cleavage by SDS-PAGE
on 12.5% polyacrylamide gels. The remainder of
the reaction volume (80 µl) was dialyzed against
0.4 % (v/v) formic acid overnight and the size of
the protein fragments was deduced from the
latter sample by ESI-mass spectrometry (Waters
quadropole time-of-flight Ultima API, Milford,
MA, U.S.A).
Light scattering - PLP synthase complex
formation was monitored by changes in 90°
scattered light intensity as described in (14). The
increase in scattered light intensity was
measured at 23°C on an Applied Photophysics
SX.18MV stopped-flow spectrometer with
excitation and emission monochromators set at
400 nm. The excitation and emission bandwidths
were set to 2 nm. The increase in scattered light
intensity was measured at an angle of 90° upon
mixing equimolar concentrations of Pdx1 and
Pdx2 H170N (1 µM) in 20 mM Tris-Cl and 10
mM NaCl, pH 7.5, in the presence of 1 mM
glutamine. In order to relate these measurements
with the observed changes in intrinsic
tryptophan fluorescence, identical measurements
were carried out following tryptophan
fluorescence essentially as described above with
the exception that 1 µM Pdx1 and Pdx2 H170N,
were used.
RESULTS
Equilibrium binding of Bacillus subtilis Pdx1
and Pdx2 - To date, the C-terminus of Pdx1, the
synthase component of the heteromeric PLP
synthase, has escaped both structural and
functional characterization. We recognised that
PLP synthase from Bacillus subtilis is a
particularly amenable system to monitor
perturbations in this region by fluorescence
spectroscopy. This is because Pdx1 from this
organism contains only a single tryptophan
residue that is at the very C-terminus, whereas
its partner protein, Pdx2, does not have any
tryptophan residues. Consequently, the
tryptophan residue in Pdx1 is an ideal probe to
monitor changes in the C-terminal region of the
protein during complex formation and substrate
binding. The fluorescence emission spectrum of
Pdx1 shows a maximum at 350 nm upon
excitation at 295 nm (Fig. 1A). Site directed
mutagenesis confirmed that the fluorescence is
due to the single tryptophan residue (Fig. 1A).
The Pdx1 fluorescence decreases 2.7% upon
incubation with a 2-fold excess of Pdx2 H170N,
while a 10-fold excess of Pdx2 H170N results in
a 6% decrease in Pdx1 fluorescence (Fig. 1B). If
in addition to a 2-fold excess of Pdx2 H170N,
glutamine was added, a larger quenching of the
Pdx1 fluorescence was observed (23%) with no
readily apparent shift in the wavelength
maximum (Fig. 1A). We therefore propose that
the fluorescence signal may comprise two
components: one is due to binding of Pdx2
H170N to Pdx1 and the other is due to a
conformation of the Pdx1/Pdx2 complex that can
only be reached when glutamine is bound to
Pdx2 H170N. However, we noted that
depending on the preparation of Pdx2 H170N,
the magnitude of the Pdx1 fluorescence
decrease, without addition of glutamine, varies
slightly. We suspect that this is a result of Pdx2
H170N co-purifying with a small amount of
glutamine, which does not dissociate from the
protein under the conditions used. Based on
these observations and the previously reported
6dissociation constant of 6.9 µ M for the
Pdx1/Pdx2 complex in the absence of glutamine
(15), we conclude that the association of Pdx1
with Pdx2 H170N causes only a fraction of the
total fluorescence signal change, while the
remaining larger contribution results from the
allosteric effect of glutamine bound to Pdx2.
Pdx2 H170N is unable to catalyze glutamine
hydrolysis, but binds glutamine in a dead-end
Michaelis complex (5) resulting in an at least 23-
fold increase in the affinity of Pdx2 for Pdx1
(15). Titration of Pdx1 with Pdx2 H170N in the
presence of added glutamine is characterized by
a decrease in fluorescence intensity as a function
of Pdx2 H170N concentration (Fig. 1C).
Saturation occurs at a Pdx1 to Pdx2 H170N
molar ratio of 0.82. The binding constant K
could be estimated by titration of Pdx1 with
Pdx2 H170N in the presence of added glutamine
under non-saturating conditions (Fig. 1D). A
plot of the relative fluorescence change against
the ligand concentration results in hyperbolic
binding behaviour yielding a Kd of 0.42 ± 0.04
µM. This value is similar to the Kd of 0.3 µM
determined by isothermal titration calorimetry
under equivalent conditions (15).
Real-time analysis of PLP synthase complex
assembly - The observed change in the intrinsic
fluorescence of Pdx1 upon interaction with Pdx2
H170N in the presence of added glutamine can
be used to determine the kinetics of PLP
synthase complex assembly. In a stopped-flow
setup, equimolar amounts of Pdx1 and Pdx2
H170N were rapidly mixed in the presence of
glutamine and either the intrinsic fluorescence
change or the change in light scattering intensity
at 400 nm was followed (Fig. 2A). The recorded
fluorescence decrease coincides with an increase
in light scattering intensity indicating that the
fluorescence time course indeed reports on
complex formation.
To obtain information on the involved
individual rate constants, stopped-flow
fluorescence measurements were performed
under pseudo first order conditions with an
excess of Pdx2 H170N in the presence of added
glutamine. The concentration dependence of the
association reaction was analyzed by varying the
Pdx2 H170N concentration (1.2-4.8 µM) while
keeping the concentration of Pdx1 constant (0.3
µM). The time courses obtained under these
conditions can be described by sums of
exponentials. The association time courses
display biphasic behavior and were analyzed by
a double exponential fit. The fast and slow
relaxation occurs in time windows that differ by
about one order of magnitude (Fig. 2B). Their
relaxation times are dependent on the
concentration of Pdx2 H170N as would be
expected for a bimolecular reaction. However,
while the accessible concentration range showed
a linear increase for the first relaxation rate
constant (1/τ1), the second relaxation rate
constant (1/τ2) appeared to be close to saturation.
Since both steps are associated with a change in
the intrinsic fluorescence of the terminal
tryptophan residue, yet the C-terminus is not
involved in the formation of the binding
interface, a fast conformational change must
already occur concomitant with formation of the
Pdx1-Pdx2 H170N complex and is then
followed by a slower conformational change
leading to a further decrease in the signal. The
data were therefore evaluated according to a
two-step mechanism with a fast equilibrating
association step followed by a slower
unimolecular step. Fitting the concentration
dependence of the first relaxation rate constant
to a linear function allows extraction of the
forward rate constant of the association step
from the slope (k1 of 1.2 ± 0.2·105 s-1·M-1) and
the reverse rate constant from the y-intercept (k-1
of 0.16 ± 0.025 s-1) (Fig. 2C). The saturating
value for the second relaxation rate constant
represents the sum of the forward and reverse
rate constants of the second, unimolecular step
(Fig. 2C, inset).
To confirm that saturation was reached for
the second relaxation rate constant, numerical
analysis employing a global fit to all
fluorescence time courses using the proposed
two-step model was carried out and corroborated
the relaxation kinetic analysis, while in addition
providing values for k2 and k-2 of 0.05 ± 0.01 s-1
and 0.015 ± 0.005 s-1, respectively (Fig. 2B,
inset). The best numerical fit was obtained when
the Pdx1:Pdx2 H170N complex holds 30% of
the total signal. In the ternary complex
(Pdx1:Pdx2 H170N:glutamine) the tryptophan-
fluorescence is further quenched (70% of the
total signal) demonstrating that glutamine affects
the active site of Pdx1 in an allosteric manner.
Substrate modulation of the proteolytic
cleavage of the flexible Pdx1 C-terminus - We
frequently noted that if Pdx1 (either without or
with a C-terminal hexa-histidine tag) is purified
7in the absence of protease inhibitors, a protein
band with slightly higher mobility, in addition to
that expected, is observed after SDS-PAGE
analysis. In the presence of a protease inhibitor
cocktail (Roche Applied Science), this band is
substantially reduced. N-terminal sequencing
and Western blot analysis with a specific
antibody confirmed that the second band is Pdx1
(data not shown) and suggested cleavage at the
C-terminus by a co-purifying protease.
Electrospray ionization mass spectrometry (ESI-
MS) of the purified native protein revealed
masses of 31480.6 and 30693.1 Da,
corresponding to the full length (expected mass
31480.4 Da; note that the starting methionine is
absent in heterologously expressed Pdx1) and a
C-terminal truncated version of Pdx1 cleaved at
arginine 288 (calculated mass 30692.5 Da).
Mass spectrometry of the histidine-tagged
protein yielded equivalent masses that result
from cleavage at the identical residue. To obtain
further insight into the susceptibility of Pdx1 to
proteolytic cleavage, a tryptic digest of the
native intact protein was carried out. Digestion
of Pdx1 with increasing concentrations of
trypsin resulted in the appearance of distinct
additional higher mobility bands after SDS-
PAGE analysis (Fig. 3A). ESI-MS revealed that
the most susceptible site of cleavage was at
arginine 288 in the C-terminus (Fig. 3B  and
Table 1). The susceptibility of Pdx1 to protease
digestion was also analysed in the presence and
absence of its substrates, i.e. either ribose 5-
phosphate or glyceraldehyde 3-phosphate or
both together. Interestingly, the addition of
either the pentose or triose phosphate substrate
alone provided noticeable protection from
cleavage, while the two together had an apparent
additive effect and substantially decreased
susceptibility to proteolytic digestion (Fig. 3A
and B, Table 1). It is noteworthy, that when
present, the pentose phosphate substrate remains
covalently bound to the protein even in the
absence of the C-terminus (manifested as an
additional mass of 212 Da (12)), whereas the
presence of the triose phosphate is not detected
under these conditions (Table 1). The covalent
binding of the pentose phosphate sugar as an
imine intermediate with an active site lysine
residue has recently been described in detail and
constitutes one of the early steps in the reaction
sequence (4,6,12). In order to assess the
susceptibility of the PLP synthase complex to
protease digestion, the experiments were
repeated as described above, but in the presence
of Pdx2 H170N and added glutamine (Figure 3A
and B , Table 1). It is apparent that the
Pdx1:Pdx2 H170N:glutamine ternary complex is
more susceptible to protease cleavage than Pdx1
alone. As for Pdx1 alone, the Pdx1 substrates
protect the ternary complex from digestion.
However, it is interesting to note that the overall
protective effect of glyceraldehyde 3-phosphate
is more pronounced in the presence of Pdx2
H170N and glutamine (Figure 3A  and B). ESI-
MS confirmed that the susceptible protease
cleavage site of Pdx1 was identical in all cases
in the presence and absence of ligand(s).
The C-terminus of Pdx1 is essential for
catalysis - To assess the function of the Pdx1 C-
terminus, a deletion mutant missing the C-
terminal 22 amino acids, Pdx1 Δ273-294, was
constructed and analyzed for enzymatic activity.
Enzyme activity can be monitored in any of
three ways, i.e. the ability to form the recently
identified chromophoric reaction intermediate
(12), the product PLP, and thirdly, the ability to
activate glutaminase activity in its partner
protein Pdx2 (3). Formation of the chromophore
with Pdx1 Δ273-294 was estimated to be 0.5%
of wild type activity (5.23 nmol min-1 mg-1),
whereas PLP formation could not be detected
with this mutant (Table 2). However, Pdx1
Δ273-294 was able to activate the glutaminase
activity of Pdx2 (147 nmol min-1 mg-1) to a
similar extent as the wild-type protein (142 nmol
min-1 mg-1) (Table 2). This indicates that the
truncated mutant has the correct 3D fold with an
intact Pdx1-Pdx2 interaction interface. A
deletion mutant in which only the C-terminal
tryptophan was deleted, Pdx1 ΔW294, displayed
activity similar to the wild type protein for
chromophore and PLP formation (Table 2),
indicating that this residue is not essential for
functionality.
Site specific incorporation of an unnatural
amino acid and crosslinking further defines the
role of the C-terminus of Pdx1 - To further
characterize the molecular role of the C-terminus
of Pdx1, we employed the recently established
powerful approach of site-specific unnatural
amino acid incorporation developed by the
group of Peter G. Schultz (11). The molecule p-
benzoyl-L-phenylalanine (pBpa) was chosen as
the probe, which is a photo-reactive
phenylalanine derivative that upon activation at
350-360 nm reacts preferentially with C-H
8bonds within a radius of 3.1 Å of the carbonyl
oxygen. Advantages of pBpa over similar probes
include that it can be manipulated in ambient
light, is chemically more stable than diazo
esters, aryl azides, or diazirines, and it can be
activated at wavelengths that do not cause
protein damage (16,17). The experiment was
designed in such a way that pBpa would be co-
translationally integrated into hexa-histidine
tagged Pdx1 at the position of either R288 (Pdx1
R288:pBpa) or the C-terminal tryptophan
residue, W294 (Pdx1 W294:pBpa). Successful
expression of either Pdx1 R288:pBpa or Pdx1
W294 :pBpa was achieved and both were
purified by Ni-NTA chromatography.
Incorporation of the unnatural amino acid was
confirmed by ESI mass spectrometry (observed
masses 32928.0 Da for Pdx1 R288:pBpa
(calculated 32929.9 Da) and 32898.0 Da for
Pdx1 W294:pBpa (calculated 32899.9 Da),
respectively). These proteins showed a reduced
ability to catalyze chromophore formation and
an undetectable level of PLP formation, but
could activate glutaminase activity in Pdx2 to
the same extent as the wild type protein,
indicating correct folding (Table 2, example
shown in supplementary Fig. 1). The attenuation
of PLP synthase activity may be due to steric
hindrance of the active site from the
incorporated pBpa molecule. Irradiation of the
purified proteins resulted in the time-dependent
formation of oligomers of Pdx1 as judged by
SDS-PAGE analysis (Fig. 4A). In each case, the
predominant oligomer formed corresponded to a
dimer, indicating cross-linking to a neighboring
Pdx1 subunit (Fig. 4A). As a proof of principle
and to control the study, a second set of
experiments were performed where we inserted
pBpa at position Y261 in Pdx1. This site was
chosen based on the available 3D structure as it
resides at the interface of the individual Pdx1
subunits in a single hexameric ring (5) and
would therefore be expected to result in efficient
crosslinking of Pdx1. Indeed, substitution of
Y261 with pBpa, followed by crosslinking,
results in the time-dependent appearance of
higher order oligomers, almost sequentially from
monomer to hexamer (Fig. 4B). Furthermore, we
also inserted pBpa at position R8 in Pdx1. This
N-terminal region is known to be the site of
interaction with Pdx2 in the PLP synthase
complex (5,6). Irradiation of Pdx1 R8:pBpa in
the presence of Pdx2 H170N and glutamine
resulted in the formation of a higher order
complex (Fig 4C , left panel). Subsequent
immunodecoration of the samples with
antibodies specific to Pdx1 and Pdx2 confirmed
exclusive heterodimer formation, whereas in the
case of Pdx1 W294:pBpa and Pdx2 H170N,
exclusive Pdx1 homomeric formation was
observed (Fig 4C, right panel).
In an attempt to map the site of crosslinking
in Pdx1 W294:pBpa, the crosslinked protein
(Fig. 4A) was subjected to tryptic digestion
followed by nano-liquid chromatography and
MALDI-TOF/TOF mass spectrometry. The
identification of peptide masses corresponding
to the sum of any expected peptide mass in the
natural protein (supplementary Table 1), plus
that of the modified peptide, i.e. the peptide in
which W294 has been substituted by pB p a
(GpBpaLEHHHHHH, the underlined residues
are additionally expressed due to incorporation
of a hexa-histidine tag, calculated mass 1391.6
Da) permits the identification of the site of
crosslinking. Using this approach, a mass
corresponding to the size of the modified peptide
plus that of the peptide containing residues 270-
276 of Pdx1 (i.e. ELGTAMK) could be clearly
identified (calculated mass 2139.99 Da,
observed mass of 2139.93 Da). The assignment
of the crosslinked peptide was confirmed by a
MALDI-MS/MS spectrum (Supplementary Fig.
2). This implies crosslinking of the very C-
terminus of Pdx1 of one subunit to the region
following helix α8″ in the C-terminal region of a
neighboring subunit. This suggests that the C-
terminus of one subunit is in close proximity to
that of a neighboring subunit under these
conditions. To bring this into the context of the
known 3D structure of Pdx1, the spatial
arrangement in this region of the protein is
highlighted (Fig. 5).
Ribose 5-phosphate triggers cooperativity
within the Pdx1 oligomeric complex - It has been
demonstrated that binding of the pentose
phosphate substrate to an active site lysine
residue in Pdx1 is one of the earliest steps in the
mechanism of this multifaceted enzyme (4,12).
The propensity of ribose 5-phosphate to perturb
the protease sensitive sites of Pdx1, in particular
the C-terminus (Fig. 3 and Table 1), indicates a
conformational change upon binding of this
substrate and prompted us to examine the effect
of the pentose phosphate on the fluorescence of
Pdx1. A comparison of the fluorescence
intensity of Pdx1 with ribose 5-phosphate
bound, to that of the substrate free enzyme,
9revealed an approximate 24% increase in the
emission maximum at 350 nm in the presence of
the pentose phosphate substrate (Fig. 6A ).
Indeed, titration of Pdx1 with ribose 5-phosphate
resulted in changes in the intrinsic protein
fluorescence. A plot of the relative fluorescence
change at 350 nm as a function of the ribose 5-
phosphate concentration exhibits sigmoidal
binding behaviour (Fig. 6B ). Nonlinear
regression analysis employing equation 2 yields
a Hill coefficient of 3.1 ± 0.2 and a K0.5 of 324.8
± 5.5 µM, indicative of cooperativity within the
Pdx1 protein complex. Intrigued by this
observation, we went on to investigate the effect
of ribose 5-phosphate on preassembled PLP
synthase. To this end, Pdx1 was preincubated
with Pdx2 H170N in the presence of added
glutamine and titrated with ribose 5-phosphate.
A plot of the Pdx1 fluorescence emission
maximum as a function of ribose 5-phosphate
again resulted in sigmoidal binding behaviour
(Fig. 6B). However, while the Hill coefficient of
the preassembled PLP synthase (2.8 ± 0.2) was
similar to that of Pdx1 alone, there was a strong
reduction in K0.5 (88.7 ± 2.1 µM). This indicates
substantially enhanced binding of the substrate
to Pdx1 in the presence of the Michaelis
complex of Pdx2 H170N and glutamine.
DISCUSSION
Here we report on the use of fluorescence
spectrophotometry, limited proteolysis and
unnatural amino acid incorporation to study
conformational changes induced in Pdx1 upon
substrate binding, and upon assembly with Pdx2
to form the PLP synthase complex. In particular,
the study focuses on the structurally and
functionally undefined C-terminal region of
Pdx1. Despite the availability of several 3D
structures of both the autonomous Pdx1 protein
(9) and its complex with Pdx2 (5,6), this region
of the protein had eluded characterization,
presumably due to its highly flexible nature. Our
study was facilitated by the fortuitous presence
of a single tryptophan residue at the very C-
terminus of B. subtilis Pdx1, and the absence of
such a residue in Pdx2. With the data reported in
hand, several conformational states can be
distinguished for Pdx1. These states are
characterised by different  chemical
environments on account of observed
differences in tryptophan fluorescence.
Binding of Pdx2 shifts the “resting”
conformational equilibrium of the Pdx1 C-
terminus and is manifested as a decrease in
fluorescence intensity (Fig. 1). In the presence of
glutamine, this decrease is substantially
enhanced such that the majority of the
conformational change can be attributed to the
Michaelis complex of Pdx2 and glutamine
(Pdx2:Gln). In spatial terms, this can be
interpreted as movement of the C-terminus to a
position that brings it into the proximity of
fluorescence quenching residues. It must be
noted that the C-terminus is spatially separated
from the site of Pdx1 interaction with Pdx2.
Thus, the change in Pdx1 tryptophan
fluorescence cannot be the result of direct
quenching by Pdx2. Instead, it must be assumed
that binding of Pdx2:Gln to Pdx1 relays
conformational changes to the C-terminus of
Pdx1. Moreover, the observed decrease in Pdx1
fluorescence in the presence of Pdx2:Gln can be
used to estimate the stoichiometry and kinetics
of PLP synthase assembly. Interestingly, two
distinct phases could be resolved, a fast
concentration-dependent phase followed by a
slower phase. A combination of stopped flow
fluorescence and light scattering established that
the fast phase corresponds to bimolecular protein
association and represents formation of a 1:1
PLP synthase complex (Fig. 2). The slower
phase must correspond to an isomerization step
after protein association. That Pdx2:Gln
modulates Pdx1, albeit remotely, upon assembly
of the PLP synthase complex is supported by
other evidence. X-ray crystallography of the
individual Pdx1 protein compared to that in
complex with Pdx2 has demonstrated that in
Pdx1, helix α2´, a region remote from the site of
interaction with Pdx2, becomes ordered upon
assembly of the PLP synthase complex (5,6).
Furthermore, the use of fluorescence
spectroscopy allowed us to demonstrate that
Pdx2:Gln dramatically enhances the affinity of
Pdx1 for the substrate ribose 5-phosphate (Fig.
6). While this indicates that binding of the
pentose phosphate is thermodynamically
favoured in the fully assembled complex, it is
noteworthy that Pdx1 alone can bind ribose 5-
phosphate as shown here (see below), and as
reported earlier (12). However, the increased
affinity for the substrate in the preassembled
PLP synthase complex provides evidence that
Pdx2:Gln must alter the distantly located
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substrate-binding pocket of Pdx1. In summary,
Pdx2:Gln is an allosteric effector of Pdx1.
Another distinct conformational state of the
Pdx1 C-terminus is observed upon binding of
the pentose phosphate substrate alone, and can
be quantitatively described by fluorescence
spectrophotometry (Fig. 6). In contrast to the
association of Pdx1 and Pdx2:Gln, binding of
the substrate to Pdx1 leads to an increase in
tryptophan fluorescence, which indicates
movement of the C-terminus to an environment
that enhances its fluorescence relative to other
states of the enzyme. This latter conformation in
the presence of the pentose phosphate sugar
shows decreased susceptibility of the C-terminus
of Pdx1 to protease digestion. Thus, it appears
that ribose 5-phosphate protects the Pdx1 C-
terminal residues.
Of major significance is the sigmoidal
dependence of the Pdx1 fluorescence signal on
the concentration of ribose 5-phosphate. This
phenomenon with a Hill coefficient of 3.2 ± 0.2
provides unequivocal evidence for positive
cooperativity in Pdx1. Generally, positive
cooperativity is a mechanism to make enzymes
more sensitive to changes in the concentration of
their substrate(s) (18). Given that many enzymes
utilize ribose 5-phosphate as a substrate, the
features described make PLP synthase appealing
by “luring” the pentose phosphate substrate into
the Pdx1 active site. In general, the alterations in
protein structure that produce cooperativity
normally involve only minor changes in the
protein subunit. In almost all cases where protein
structures have provided a detailed picture of the
conformational change, it is most commonly
observed that one domain in the structure moves
a small amount relative to another domain. Such
a motion can either be a hinge-like closure or
opening, or a rotational movement. The question
then arises as to what is triggering this signaling
cascade in Pdx1. Based on the results reported
herein and the available 3D structures of Pdx1
(5,6), a hypothesis explaining the co-operative
behaviour and suggested allostery induced by
Pdx2:Gln can be attempted at the structural
level. Of particular interest is the identity of the
signal(s), which either reports ribose 5-
phosphate binding to a neighboring substrate
binding site in Pdx1, thus conferring
cooperativity, or indeed the nature of the signal
instigating the allosteric rearrangement by
Pdx2:Gln. To this end, a brief recapitulation of
the quaternary structure of Pdx1 is appropriate.
Pdx1 is a (β/α)8-barrel, six subunits of which
assemble to form a hexameric ring. Two
hexameric rings join in a head-to-head fashion to
form a dodecameric architecture (5,6,9).
Intersubunit contacts between adjacent (β/α)8-
barrels within one hexamer are mainly
established by a bulge created by helix α8´´ at
the C-terminus running parallel to helix α8. The
active site of Pdx1 is located at the C-terminal
side of the (β/α)8-barrel and faces the center of
the ring-like structure. Insight into the
organization of the active site was obtained from
the solving of the 3D structure of pent(ul)ose-
complexed Pdx1 and various mutagenesis
studies (5,6). The pent(ul)ose substrate is
covalently linked to an active site lysine residue
of Pdx1 as an imine adduct at C2, and anchored
through its phosphate group at C5 (6,12).
Structural elements participating in phosphate
anchoring involve residues from loop 6, alpha
helices α2´ and α8´, and the macrodipole of α8´
(6). A comparison of apoenzyme with the
pentose phosphate substrate bound enzyme
reveals that alterations occurring in the protein
structure are almost exclusively restricted to
helices α2´and α8´ (19). In particular, both
helices move closer to the pentose phosphate
substrate, presumably tightening the active site.
It is therefore suggested that these helices are
key players in inducing the conformational
change(s) that alter the pentose phosphate-
binding pocket of Pdx1. As ordering of helix α2´
in Pdx1 is only triggered upon assembly with
Pdx2, it must be assumed that this part of the
protein is mainly responsible for the observed
increase in substrate affinity in the presence of
the glutaminase subunit. However, neither α2´
nor α8´ directly contact bound substrate at a
neighboring subunit, thereby necessitating the
existence of structural elements that function as
a relay, to explain cooperativity. As the C-
terminus of Pdx1 is downstream of α8´, it would
appear to fulfil the requirements. Indeed, this
implication is not without precedent, as an extra
10 residues (270-280, Thermotoga maritima
numbering) of the C-terminus are observed in
the Pdx1 crystal structure when the pent(ul)ose
phosphate substrate is bound (6). Moreover,
these residues are observed to fold over towards
the active site of a neighboring subunit. In
particular, contacts to loop β6-α6, helix α8´´ and
residues 57-59 of the active site loop of an
adjacent monomer were observed. However, the
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remaining 14 residues of the C-terminus have
eluded structural characterization and their
location in 3D space has continued to be a
matter of intrigue. In this study, crosslinking of
the C-terminal residue through incorporation of
a photoactivatable probe combined with mass
spectrometry allowed us to demonstrate that this
region of Pdx1 resides in the region of residues
270-276 of a neighboring subunit (Fig. 4). This
implies that under the conditions used in the
experiment, the C-terminus of one monomer
stretches over an adjacent monomer and is
within 3.1 Å of the C-terminal residues 270-276,
just beyond helix α 8´´. Thus, the inherent
flexibility in the C-terminus of Pdx1 as seen in
the crystal structures, is confirmed by this study
and shown to be functionally relevant. The
conformational states supposed are depicted
diagrammatically in Scheme 1. Conformational
flexibility is a common feature of enzymes,
often used to control chemical reactivity or to
deliver a signal from one macromolecule to
another. It is, therefore, proposed that the C-
terminus of Pdx1 acts as a “lever” bridging
adjacent Pdx1 monomers. Indeed, the triggering
of a change in the flexibility of the C-terminus
by the pentose phosphate substrate could be
explained by helix α 2´ and α8´´ acting as
“ropes”, pulling the lever into a less exposed
environment. One cannot help but speculate that
it is the binding of the triose substrate that
bestows rigidity to the C-terminus and closes the
active site to allow catalysis to occur. Indeed,
this conclusion is corroborated by the limited
protease digestion experiments, where in the
first instance a decrease in susceptibility is
observed in the presence of glyceraldehyde 3-
phosphate (albeit not as pronounced as that
observed with ribose 5-phosphate) (Fig. 3).
Moreover, the presence of both substrates almost
completely protects the C-terminus from
digestion under these conditions. It is
noteworthy that two phosphate-binding sites (P1
and P2) have been identified in Pdx1 (5,6). Only
one phosphorylated substrate can be
accommodated at any one time in either P1 or
P2 due to an otherwise clash of the phosphate
groups. The obvious additive protection from
protease digestion afforded by the presence of
both substrates compared to either one alone
(Fig. 3), suggests the interesting possibility that
the phosphorylated substrates individually
occupy the separate phosphate binding sites.
Future studies directed at the assignment of the
triose-binding site should clarify this matter.
In light of the above data, a functional role
for the C-terminus of Pdx1, either as a mediator
of cooperativity or as a protective agent
shielding the substrate binding pocket and
perhaps recruiting an essential catalytic group to
the active site, is justified. In this context, it is
interesting to note that while the amino acid
residues of the Pdx1 C-terminus are not highly
conserved (Supplementary Fig. 3), a number of
conserved residues could be conceived to play a
catalytic role, e.g. R288 or R292. Logically, the
elucidation of the structure of the entire C-
terminus of Pdx1 should assist in defining the
exact role of these residues in catalysis.
In summary, this study provides evidence
for a highly regulated PLP synthase. On the one
hand, cooperative binding of the pentose
phosphate substrate is observed between the
Pdx1 active sites, a phenomenon that is further
regulated by Pdx2:Gln in that it enhances
substrate affinity. The fact that Pdx2:Gln
enhances the affinity for ribose 5-phosphate in
Pdx1 is most likely to signal that it is “ready” to
proceed with glutamine hydrolysis, a step that is
necessary for the transformation of the pentose
phosphate substrate into the chromophoric
intermediate (12). In this way, the efficacy of the
reaction is ensured. The inter-subunit cross-talk
features appear to be manifested either directly
or indirectly through the C-terminus of Pdx1.
Conformational coupling between monomers
provides a mechanism for tight regulation,
thereby increasing the dynamic range of sensing
events by positive cooperativity. This not only
provides an explanation for the functional
essentiality of the C-terminus, but also
rationalizes the ornate Pdx1 architecture that
manifests cooperativity. Many enzymes use
segmental motions to regulate catalysis. A
common element in these mechanisms is an
active site loop, wherein an open form can
facilitate ligand binding and release, and a
closed form prepares, controls and protects a
reaction intermediate (20,21). Indeed, this
feature has already been demonstrated for E. coli
pyridoxine 5´-phosphate synthase, the key
enzyme of the DXP-dependent pathway of
vitamin B6 biosynthesis. Extensive structural
studies have highlighted the importance of an
active site loop (loop 4) in catalysis by this
enzyme, where the loop acts as a lid, opening or
closing the active site depending on whether
12
substrate is present (22-24). The C-terminus of
the unexpectedly closely related Pdx1 with
respect to tertiary structure and function (19)
would appear to provide the same function in
PLP synthase.
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FIGURE LEGENDS
Fig. 1. Analysis of PLP synthase complex formation by fluorescence spectroscopy. (A) Fluorescence
emission spectra of 2 µM Pdx1 (black solid line), 2 µM Pdx1 with 4 µM Pdx2 H170N (black dashed
line), 2 µM Pdx1 ΔW294 (gray solid line) and 2 µM Pdx1 ΔW294 with 4 µM Pdx2 H170N (black
dotted line) in the presence of 1 mM added glutamine, after excitation at 295 nm. (B) Fluorescence
emission spectra of 2 µM Pdx1 (black solid line), 2 µM Pdx1 with 4 µM Pdx2 H170N (black dotted
line) and 2 µM Pdx1 with 20 µM Pdx2 H170N (black dashed line) in the absence of added glutamine.
(C) Relative fluorescence change of Pdx1 (2 µM) at 350 nm (excitation λ = 295 nm) in the presence
of increasing concentrations of Pdx2 H170N (0.1 to 6 µM) and added glutamine (1 mM). (D)
Quenching of Pdx1 fluorescence under non-saturating conditions, i.e. 0.3 µM Pdx1 with increasing
concentrations of Pdx2 H170N (0.05-3.0 µM). Shown is a plot of the relative fluorescence intensity at
350 nm (excitation λ = 295 nm) versus the concentration of Pdx2 H170N. Binding data were fitted
using non-linear regression according to equation 1 yielding a value of 0.42 ± 0.04 µM for the Kd. All
measurements were carried out at 23°C.
Fig. 2. Assembly of the PLP synthase complex monitored by stopped-flow fluorescence and light
scattering spectroscopy. (A) Combining fluorescence spectroscopy and light scattering to characterize
PLP synthase complex assembly. Equimolar concentrations of Pdx1 and Pdx2 H170N (1 µM) in the
presence of added glutamine (1 mM) were rapidly mixed in a stopped flow apparatus, resulting in an
increase in the scattered light intensity (gray trace) with a concomitant decrease in fluorescence
intensity (black trace). (B) Time dependent change in the intrinsic protein fluorescence of Pdx1 (0.3
µM) upon rapid mixing with Pdx2 H170N (1.2 µM, 2.4 µM and 4.2 µM) in the presence of added
glutamine (1 mM). The black curves through the experimental data (gray traces) correspond to a
double exponential fit. The fits are described by equation 3 (experimental procedures). The inset
displays a global numerical fit to the fluorescence time courses using the two-step model
A+B→C→D, where the first equilibrium is described by k1 and k-1 and the second by k2 and k-2,
respectively. (C) Values of the observed relaxation rate constants (1/τ1) for the fast phase of PLP
synthase complex formation as a function of Pdx2 equilibrium concentration. The concentration of
Pdx1 was held constant at 0.3 µM, while Pdx2 H170N was varied in the range of 1.2-4.2 µM. The
black line through the experimental data corresponds to a linear fit yielding the rate constants k1 and
k-1 of the Pdx1-Pdx2 association reaction. The inset shows the relaxation rate constants (1/τ2) of the
slow relaxation as a function of Pdx2 concentration. All measurements were carried out in 20 mM
Tris-Cl, 10 mM NaCl pH 7.5 at 23°C.
Fig. 3. Mapping flexible sites of Pdx1 by limited proteolysis and mass spectrometry. (A) SDS-PAGE
analysis of Pdx1 (32 µg) incubated with trypsin (0.0005-0.005 µg) in the presence and absence of
ligand(s). Lane 1, Pdx1 as isolated; lanes 2-4, Pdx1 in the presence of 0.0005, 0.0028 and 0.005 µg
trypsin, respectively; lanes 5-7, as for lanes 2-4, but in the presence of 1 mM ribose 5-phosphate;
lanes 8-10, as for lanes 2-4, but in the presence of 1 mM DL-glyceraldehyde 3-phosphate; lanes 11-
13, as for lanes 2-4, but in the presence of 1 mM ribose 5-phosphate and 1 mM DL-glyceraldehyde 3-
phosphate; lanes 14-25 as for lanes 2-13, but in the presence of Pdx2 H170N (30 µg) and glutamine (1
mM). In all cases, the samples were incubated for 10 min at 37°C in 20 mM Tris-Cl, pH 7.5, before
application to the gel. For Pdx1 and Pdx2 H170N, 0.8 and 0.75 µg of each protein, respectively, was
loaded per lane. Protein was visualized by Coomassie Blue staining and the mobility of protein mass
standards are as indicated. The black blocks indicate a progressive increase in the concentration of
trypsin. (B) ESI mass spectra of selected samples from (A). Samples were digested with 0.005 µg
trypsin, in the presence or absence of ligands as indicated. The left top panel is the spectrum of
untreated Pdx1, while the diagram beside it depicts the observed protease cleavage site. The numbers
inset in the panels of the spectra represent the ratio of full length to truncated Pdx1 as judged by the
intensity of the respective peaks.
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Fig. 4. Molecular characterisation of the C-terminus of Pdx1 by site-specific incorporation of the
unnatural amino acid, pBenzoyl-L-phenylalanine (pBpa). (A) Time-dependent crosslinking of Pdx1
W294:pBpa or Pdx1 R288:pBpa, analyzed by SDS-PAGE (12.5%). The mutant proteins (5 µM) were
irradiated by UV light for the times indicated prior to separation. The arrowheads indicate bands
corresponding to dimers. (B) Time-dependent crosslinking of Pdx1 Y261:pBpa (left panel) and after
probing with an antibody specific to Pdx1 to demonstrate oligomerization (right panel). (C)
Characterization of Pdx1 R8:pBpa and Pdx1 W294:pBpa crosslinked products by SDS-PAGE and
Western blot analysis. Left: Analysis of Pdx1 R8:pBpa protein (lanes 1 to 4) either incubated alone
(lanes 1, 2) or with Pdx2 H170N in the presence of glutamine (lanes 3, 4)  and with (+) or without (-)
60 minutes of exposure to UV light. Western blots of the same samples were carried out and probed
with either αPdx1 or αPdx2 antibodies as indicated. Right: Analysis of Pdx1 W294:pBpa under the
same conditions as described for the left panel. The mobility of the standards were as indicated.
Fig. 5. The architecture of the PLP synthase protein complex (PDB 2ISS). Pdx1 monomers are shown
in orange and white, while Pdx2 is shown in green. The area between adjacent Pdx1 monomers is
expanded. On monomer one (white) the terminal residue of the resolved structure is highlighted
(yellow) (Note: residues 280-293 were unresolved and are therefore missing in the structure), while
on monomer two (orange) the area following helix α8″, which is implicated to be in close proximity
to the C-terminal residue based on crosslinking, is highlighted (red), i.e. residues 271-277 (Note:
Thermotoga maritima numbering). The co-crystallized substrate ribulose 5-phosphate is shown in ball
and stick representation The picture was prepared using PyMOL (25).
Fig. 6. Probing ribose 5-phosphate binding to Pdx1 by fluorescence spectroscopy. (A) Normalized
fluorescence intensity of 2 µM apoPdx1 (solid line) and with R5P bound (dashed line) after excitation
at 295 nm. (B) Titration of either apoPdx1 (2 µM) or preassembled PLP synthase (apoPdx1 (1 µM)
and Pdx2 H170N (2 µM) in the presence of glutamine (1 mM) incubated for 5 min at 37°C) with
increasing concentrations of ribose 5-phosphate (25-910 µM). A plot of the relative fluorescence
change at 350 nm (excitation λ = 295 nm) versus the concentration of ribose 5-phosphate
demonstrates sigmoidal binding behaviour. For apoPdx1 alone, fitting to equation 2 using non-linear
regression yields values of 3.1 ± 0.2 and 324.8 ± 5.5 µM for the Hill coefficient and K0.5, respectively.
Preassembled PLP synthase exhibits similar sigmoidal binding behaviour to that of apoPdx1, but with
a Hill coefficient and K0.5 of 2.8 ± 0.2 and 88.7 ± 2.1 µM, respectively.
Scheme 1. Representative conformational states for PLP synthase. Free Pdx1 is in equilibrium
between at least two different conformations, being characterized by the degree of exposure of the C-
terminal tail (dashed lines) (I). The Pdx1:Pdx2:Gln ternary complex favors a more open conformation
in the absence of ligand (II). The presence of ribose 5-phosphate (S1) adds protection to the C-
terminus and leads to a partially closed conformation (III). In the presence of both ribose 5-phosphate
(S1) and glyceraldehyde 3-phosphate (S2) a closed conformation is favored (IV). In each case the
solid line represents the favored conformation.
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Table 1. Susceptibility of Pdx1 to partial proteolytic cleavage. The presence of the substrates, ribose
5-phosphate (R5P) or glyceraldehyde 3-phosphate (G3P), and Pdx2 H170N are as indicated. In all
cases 0.005 µg of trypsin was used.
Pdx2 H170N/glutamine Pdx1 mass observed(Da) Pdx1 cleavage site
31484.4 -
-
30692.5 R288
31484.0 -
N
o 
su
bs
tr
at
e
+
30693.5 R288
31693.0 -
-
30905.0 R288
31694.0 -R
5P
+
30906.0 R288
31481.5 -
-
30693.0 R288
31481.5 -G
3P
+
30691.5 R288
31693.5 -
-
30905.0 R288
31693.5 -
R
5P
/G
3P
+
30905.5 R288
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Table 2. Specific enzyme activity of Pdx1 variants. Three distinct activities can be measured, the
propensity to a) form the catalytic chromophoric intermediate (chromophore); b) form the product
pyridoxal 5´-phosphate (PLP); c) activate glutaminase activity in Pdx2 (glutaminase activity).
Chromophore
Specific Activity
PLP
Specific Activity
pmol min-1 mg-1
Glutaminase activity
Specific Activity
nmol min-1 mg-1
Pdx1 WT 5.2 ± 0.3 nmol min-1 mg-1 480.7 ± 13.93 142 ± 0.2
Pdx1 R288:pBpa 1.1 ± 0.2 nmol min-1 mg-1 Not detectable 138 ± 0.2
Pdx1 W294:pBpa 1.3 ± 0.1 nmol min-1 mg-1 Not detectable 133 ± 0.2
Pdx1 ΔW294 4.7 ± 0.3 nmol min-1 mg-1 413.1 ± 19.2 Not measured
Pdx1 Δ273-294 27.7 ± 1.6 pmol min-1 mg-1 Not detectable 147 ± 0.2
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SUPPLEMENTARY DATA
Supplementary Table 1. Expected peptide masses of Pdx1 W294:pBpa. Note: position –2 and –1 refer to the
residues AS expressed due to the cloning strategy employed. The observed predicted cross-linked mass is
highlighted.
Position Peptide sequence Expected Mass[M+H]+
Predicted crosslinked
Mass [M+H]+
293-302 GpBpaLEHHHHHH 1391.6 -
-2-8 ASMAQTGTER 1050.5 2442.1
9-10 VK 245.2 1636.8
12-18 GMAEMQK 793.4 2185.0
19-32 GGVIMDVINAEQAK 1443.7 2835.3
33-47 IAEEAGAVAVMALER 1528.8 2920.4
48-53 VPADIR 669.4 2061.0
54-60 AAGGVAR 600.3 1991.9
61-81 MADPTIVEEVMNAVSIPVMAK 2244.1 3635.7
82-83 AR 245.2 1636.8
84-91 IGHIVEAR 893.5 2285.1
92-118 VLEAMGVDYIDESEVLTPADEEFHLNK 3062.4 4454.0
119-130 NEYTVPFVCGCR 1386.6 2778.2
131-137 DLGEATR 760.4 2152.0
139-147 IAEGASMLR 946.5 2338.1
148-149 TK 247.2 1638.8
150-162 GEPGTGNIVEAVR 1297.7 2689.3
163-165 HMR 442.2 1833.8
167-172 VNAQVR 685.4 2077.0
174-187 VVAMSEDELMTEAK 1551.7 2943.3
188-200 NLGAPYELLLQIK 1470.8 2862.4
202-204 DGK 318.2 1709.8
205-240 LPVVNFAAGGVATPADAALM-MQLGADGVFVGSGIFK 3490.8 4882.4
241-246 SDNPAK 630.3 2021.9
247-249 FAK 364.2 1755.8
250-262 AIVEATTHFTDYK 1494.7 2886.3
263-269 LIAELSK 772.5 2164.1
270-276 ELGTAMK 748.4 2139.9
277-288 GIEISNLLPEQR 1367.7 2759.3
289-292 MQER 562.3 1953.9
293-302 GWLEHHHHHH 1325.6 -
Supplementary Figure 1 legend. Glutaminase activity of Pdx1 W294:pBpa versus Pdx1 wild-type (WT). The
assay is performed by coupling glutaminase activity of Pdx1 and Pdx2 (4 µM each, 10 mM glutamine) with
glutamate dehydrogenase, which converts glutamate to α-ketoglutarate with the concomitant reduction of
APAD (0.5 mM) as described in (1).
Supplementary Figure 2 legend. MALDI-MS/MS spectrum of a crosslinked peptide dimer consisting of α
chain, GpBpaLEHHHHHH, and β chain, ELGTAMK. The [M+H]+ signal at m/z 2139.99 was selected as
the precursor ion. The product ions formed were labeled according to the nomenclature suggested in (2). In
brief, the two intermolecularly crosslinked peptides, GpBpaLEHHHHHH and ELGTAMK, are labeled α and
β. Cleavage along the backbone of the α peptide yielding a b ion is labeled as bnα, and similar notation is
used for other fragment ion types as well as for the β peptide.
Supplementary Figure 3 legend. Amino acid sequence alignment of the C-terminus of Pdx1. The asterisk and
boxed residues are those equivalent to R288 in Bacillus subtilis (BsPdx1). The other sequences shown are
from Arabidopsis thaliana (AtPDX1.1-AtPDX1.3), Oryza sativa (OsPDX1), Gingko biloba (GbPDX1),
Plasmodium falciparum (PfPdx1), Plasmodium yoelli (PyPdx1), Emericella nidulans (EnPdx1), Cercospora
nicotianiae (CnPdx1), Saccharomyces cerevisiae (ScSNZ1-ScSNZ3), Thermotoga maritima (TmPdx1),
Pyrococcus horikoshii (PhPdx1).
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H H I N K H N F R I P F V C G C R N L G E A L R R I A E G A A M I R T K G E - A G T G N V I E A V R H V R S V L G D I R K L Q S L - - - - - - D D D - - - - - - - 130 Ginko biloba
H H I D K H K F K T P F V C G C T N L G E A L R R I S E G A S M I R T K G E - A G T G N I I E A I K H I R T V N N E I K Y L C S L S D S - - - - - - - - - - - - - 116 P.falciparum PDX1
N H I N K H K F K T P F V C G C T N L G E A L R R I S E G A S M I R T K G E - A G T G N I I E A I K H I R T V N N E I K Y L C S L D E S - - - - - - - - - - - - - 117 P.yoelli
Y H V T K H N F K A P F V C G C R N L G E A L R R I S E G A A M I R T K G E - A G T G D V V E A V K H M R T V N A E I A R A R A I L Q S S P D P E P - - - - - - - 118 E.nidulans
N H I D K S V Y N V P F V C G C K N L G E A L R R I S E G A A M I R T K G E - A G T G D V V E A V R H M Q T V N A E I A K A - - - - - - S S A S D A - - - - - - - 163 C.nicotianae PDX1
H H I E K D K F K V P F V C G A K D L G E A L R R I N E G A A M I R T K G E - A G T G D V S E A V K H I R R I T E E I K A C Q Q - - - - - - - - - - - - - - - - - 113 S.cerevisiae SNZ1
H H I E K H N F K V P F V C G A K D L G E A L R R I N E G A A M I R T K G E - A G T G D V S E A V K H I T K I K A E I Q Q Y K E - - - - - - - - - - - - - - - - - 111 S.cerevisiae SNZ2
H H I E K H N F K V P F V C G A K D L G E A L R R I N E G A A M I R T K G E - A G T G D V S E A V K H I T K I K A E I Q Q Y K E - - - - - - - - - - - - - - - - - 111 S.cerevisiae SNZ3
F H L N K N E Y T V P F V C G C R D L G E A T R R I A E G A S M L R T K G E - P G T G N I V E A V R H M R K V N A Q V R K V V A M S E D E L M T E A K N L G A P Y 113 B.subtilis
F H I N K H E F K V P F V C G A R D L G E A L R R I A E G A A M I R T K G E - A G T G N V V E A V K H M R R V M E Q I K Q V T K M E D E E L - - - - - - - - - - - 115 T.maritima
F H I Y K K K F T A P F V C G A R N L G E A V R R I W E G A A M I R T K G E - A G T G N I I E A V R H V R L V N E N I R L I Q R M T D E E I Y G V A E K F A E P Y 120 Pyrococcus horikoshii
- - - - - - - - - - - - - - - - - - - - - - - - E V F - F A K E L A A P Y D L L L Q T K Q L G R L P V V N F A A G G V A T P A D A A L M M Q L G C D G V F V G S G Majority
250 260 270 280 290 300 310 320
- - - - - - - - - - - - - - - - - - - - - - - - E V F T Y A K K I A A P Y D L V V Q T K E L G R L P V V Q F A A G G V A T P A D A A L M M Q L G C D G V F V G S G 198 A.thaliana PDX1a 2g38230
- - - - - - - - - - - - - - - - - - - - - - - - E V F T F A K K I S A P Y D L V A Q T K Q M G R V P V V Q F A S G G I T T P A D A A L M M Q L G C D G V F V G S E 202 A.thaliana PDX1b 3g16050
- - - - - - - - - - - - - - - - - - - - - - - - E V F T F A K K L A A P Y D L V M Q T K Q L G R L P V V Q F A A G G V A T P A D A A L M M Q L G C D G V F V G S G 197 A.thaliana PDX1c 5g01410
- - - - - - - - - - - - - - - - - - - - - - - - E V F S Y A K R I A A P Y D L V M Q T K Q L G R L P V V Q F A A G G V A T P A D A A L M M Q L G C D G V F V G S G 199 Oryza sativa
- - - - - - - - - - - - - - - - - - - - - - - - E V F A F A K Q I A A P Y E L V R Q T K Q L G R L P V V N F A A G G V A T P A D A A L M M Q L G C D G V F V G S G 197 Ginko biloba
- - - - - - - - - - - - - - - - - - - - - - - - E V Y H F A K K I N A P I D L V L L T K K L K R L P V V N F A A G G V A T P A D A A M C M Q L G M D G V F V G S G 183 P.falciparum PDX1
- - - - - - - - - - - - - - - - - - - - - - - - E V Y N F A K K L R A P I D L I L L T R K L K R L P V V N F A A G G I A T P A D A A M C M Q L G M D G V F V G S G 184 P.yoelli
- - - - - - - - - - - - - - - - - - - - - - - - E L R A Y A R E L E A P Y E L L R E A A E K G R L P V V N F A A G G V A T P A D A A L M M Q L G C D G V F V G S G 191 E.nidulans
- - - - - - - - - - - - - - - - - - - - - - - - D L R M M A R E L Q C D Y N L L K Q T A Q L K R L P V V N F A A G G I A T P A D A A L M M Q M G C D G V F V G S G 230 C.nicotianae PDX1
- - - - - - L K S E D D I A K V - - - - - - - - - - - - - A E E M R V P V S L L K D V L E K G K L P V V N F A A G G V A T P A D A A L L M Q L G C D G V F V G S G 176 S.cerevisiae SNZ1
- - - - - N L K T E S D F A A K - - - - - - - - - - - - - A T E L R V P V D L L K T T L S E G K L P V V N F A A G G V A T P A D A A L L M Q L G C E G V F V G S G 174 S.cerevisiae SNZ2
- - - - - N L K T E S D F A A K - - - - - - - - - - - - - A T E L R V P V D L L K T T L S E G K L P V V N F A A G G V A T P A D A A L L M Q L G C E G V F V G S G 174 S.cerevisiae SNZ3
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - E L L L Q I K K D G K L P V V N F A A G G V A T P A D A A L M M Q L G A D G V F V G S G 193 B.subtilis
- - V A Y G - K E I G A - - - - - - - - - P V - - - - - - - - - - - - - - E L L R E V K R L G R L P V V N F A A G G V A T P A D A A L M M M L G A D G V F V G S G 184 T.maritima
L R L A F S V K E I S G L P K R V L E N E P I Y E G F T Y R E I V E D I Y K I L L E I K K L G R L P V V N F A A G G V A T P A D A A L M M A M G M D G V F V G S G 200 Pyrococcus horikoshii
I F K S G D P A K R A K A I V Q A V T H Y D D P K V L A E V S S G L G E A M V G I N I S S L K - - - - - - E E R L A E R G W Majority
330 340 350 360 370 380
V F K S G D P V K R A K A I V Q A V T N Y R D A A V L A E V S C G L G E A M V G L N L - D D K V - - - - - - E R F A S R S E                                       255 A.thaliana PDX1a 2g38230
V F D G P D P F K K L R S I V Q A V Q H Y N D P H V L A E M S S G L E N A M E S L N V R G D R I Q D - - - - - - F G Q G S V                                       259 A.thaliana PDX1b 3g16050
I F K S G D P A R R A R A I V Q A V T H Y S D P E M L V E V S C G L G E A M V G I N L N D E K V - - - - - - E R F A N R S E                                       254 A.thaliana PDX1c 5g01410
I F K S G D P A L R A R A I V Q A V T H Y S D P K I L A E V S S G L G E A M V G I N L S D P K I - - - - H V E R F A A R S D                                       256 Oryza sativa
V F K S G D P A R R A R A I V Q A V T H Y N D P H I L A E V S C S L G E A M V G I N L K D E K V - - - - - - E R Y A E R S E                                       254 Ginko biloba
I F E S E N P R K M A A S I V S A V S N F N N P K I L L D V S M N L G K A M C G S T R V S D K W K N K N E E H T K F L T P Q                                       240 P.falciparum PDX1
I F E S E N P Q K M A S S I V M A V S N F N N P K I L L N V S L G L G K A M H G N T K V S N K W K N K S E E D N S                                                 241 P.yoelli
I F K S G D A K K R A K A I V Q A V T H Y K D P K V L A E V S Q G L G E A M V G I N V S H M K - - - - - D E D K L A K R G W                                       248 E.nidulans
I F K S G D A A K R A K A I V Q A T T H Y N D P K V L A E V S S G L G E A M V G I N C D K L P - - - - - E T Q K L A T R G W                                       287 C.nicotianae PDX1
I F K S S N P V R L A T A V V E A T T H F D N P S K L L E V S S D L G E L M G G V S I E S I S H A S - - N G V R L S E I G W                                       238 S.cerevisiae SNZ1
I F K S S D P E K L A C A I V E A T T H Y D N P A K L L Q I S S D L G D L M G G I S I Q S I N E A G G K N G A R L S E I G W                                       237 S.cerevisiae SNZ2
I F K S S D P E K L A C A I V E A T T H Y D N P A K L L Q V S S D L G D L M G G I S I Q S I N E A G G K N G A R L S E I G W                                       237 S.cerevisiae SNZ3
I F K S D N P A K F A K A I V E A T T H F T D Y K L I A E L S K E L G T A M K G I E I S N L - L - - - - P E Q R M Q E R G W                                       237 B.subtilis
I F K S K D P R K M A K A M V L A V T Y W D N P R I L L K I S E D I G E P M R G L D V E E L - - - - - - - E V R M Q E R G W                                       239 T.maritima
I F K S S N P P K M A R A I V E A V N H W D E P D V L A E I S R E I G E P M R G Q A I E E L - - - - - - - Q V R M E E R G I                                       281 Pyrococcus horikoshii
Decoration 'Decoration #1': Shade (with solid deep red) residues that match the Consensus exactly.
* AtPDX1.1
AtPDX1.2
AtPDX1.3
OsPDX1
GbPDX1
PfPdx1
PyPdx1
EnPdx1
CnPdx1
ScSNZ1
ScSNZ2
ScSNZ3
BsPdx1
TmPdx1
PhPdx1
Supplementary Figure 3
